Azobenzenes
eMolecules Ambeed / Dimethyl pyridine-25-dicarboxylate / 1g / 552704469 / A316473 / / 881-86-7 / MFCD00034767 / 195.174 / C9H9NO4
Ambeed / Dimethyl pyridine-25-dicarboxylate / 1g / 552704469 / A316473 / / 881-86-7 / MFCD00034767 / 195.174 / C9H9NO4
Medchemexpress LLC Atuliflapon (AZD5718) | 2041075-86-7 | 99.0% | 25 MG
Atuliflapon (AZD5718) is a small-molecule, orally active inhibitor of 5-lipoxygenase activating protein (FLAP) used in preclinical and clinical research to modulate leukotriene biosynthesis and investigate cardiovascular inflammation.
- Inhibits FLAP with low-nanomolar potency in clinical studies.
- Demonstrates target engagement via reduced LTB4 and LTE4 biomarkers.
- Suitable for in vitro human and translational studies; species-dependent activity limits some animal models.
- Provided as a solid powder with high purity for research use.
Medchemexpress LLC FzM1.8 50mg | 2204290-85-5 | 322.31 g/mol | C18H14N2O4 | 50 MG
FzM1.8 is a small-molecule allosteric agonist of the Frizzled receptor FZD4 that activates the WNT/β-catenin signaling pathway by promoting TCF/LEF transcriptional activity in the absence of WNT ligand. The compound is provided as a research-grade, purified material with reported physicochemical and handling data suitable for in vitro and in vivo studies.
- Allosteric agonist of FZD4 that activates the WNT/β-catenin pathway.
- Suitable for in vitro and in vivo research applications.
- High reported purity (98.93%) for reproducible results.
- Molecular formula C18H14N2O4 and molecular weight 322.31 g/mol.
- Soluble in DMSO (≈83.33 mg/mL) and formulatable for in vivo dosing.
- Recommended storage: powder -20°C (3 years) or 4°C (2 years); in solvent -80°C (2 years).
![Medchemexpress LLC 4-[[(2,3-dihydro-1,1,3,3-tetramethyl-2-oxo-1H-inden-5-yl)carbonyl]amino]-benzoic acid | 215307-86-1 | MFCD18384955 | 98.9% | 351.40 Da | C21H21NO4 | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000239783.png-250.jpg)
Medchemexpress LLC 4-[[(2,3-dihydro-1,1,3,3-tetramethyl-2-oxo-1H-inden-5-yl)carbonyl]amino]-benzoic acid | 215307-86-1 | MFCD18384955 | 98.9% | 351.40 Da | C21H21NO4 | 5 MG
BMS 753 (CAS 215307-86-1) is an isotype-selective retinoic acid receptor α (RARα) agonist with a reported Ki of 2 nM. Supplied as a research-grade powder, it has molecular formula C21H21NO4 and molecular weight 351.40 Da, and is provided with high purity for laboratory use. The compound is intended for in vitro pharmacology and receptor signaling studies and requires low-temperature storage when in solvent.
![Medchemexpress LLC 4-methyl-2-(4-methylpiperazinyl)pyrimido[4,5-b]benzothiazine | 928853-86-5 | 98.5% | 313.42 | C16H19N5S | 100 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000307833.png-250.jpg)
Medchemexpress LLC 4-methyl-2-(4-methylpiperazinyl)pyrimido[4,5-b]benzothiazine | 928853-86-5 | 98.5% | 313.42 | C16H19N5S | 100 MG
4-MMPB (CAS 928853-86-5) is a small-molecule research compound that selectively inhibits 15-lipoxygenase and has been used in studies of cancer biology. It is provided as a high-purity research reagent with characterized activity and recommended storage conditions for long-term stability.
- Selective 15-lipoxygenase inhibitor with reported IC50 ≈ 18 μM.
- High purity suitable for research (≈98.5%).
- Available in small pack sizes for laboratory use, including solid and solution formats.
- Recommended storage: powder at -20°C (up to 3 years) or 4°C (up to 2 years); in solvent at -80°C (up to 6 months) or -20°C (up to 1 month).
- Molecular formula C16H19N5S and molecular weight 313.42, suitable for analytical characterization.
Medchemexpress LLC C-021 | 864289-85-0 | 100.0% | 467.65 g/mol | C27H41N5O2 | 25 MG
C-021 is a small-molecule CCR4 antagonist supplied for research use. It inhibits CCR4-mediated chemotaxis in human and mouse cells and blocks CCL22-induced GTPγS binding, making it suitable for biochemical and cellular assays.
- Target: CCR4 (GPCR), suitable for immunology and GPCR research.
- Potent CCR4 antagonist with reported IC50s of 140 nM (human chemotaxis), 39 nM (mouse chemotaxis), and 18 nM in GTPγS binding assays.
- Molecular formula C27H41N5O2 and molecular weight 467.65 g/mol.
- Reported purity 99.95% and solid appearance (off-white to light yellow).
- Recommended storage: powder -20°C (up to 3 years) or 4°C (up to 2 years); in solvent -80°C (6 months) or -20°C (1 month).
- Intended for research use only; not for human or animal therapeutic use.
![Medchemexpress LLC 2-([1,4'-bipiperidin]-1'-yl)-N-cycloheptyl-6,7-dimethoxyquinazolin-4-amine | 864289-85-0 | 100.0% | 467.65 g/mol | C27H41N5O2 | 100 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000244776.png-250.jpg)
Medchemexpress LLC 2-([1,4'-bipiperidin]-1'-yl)-N-cycloheptyl-6,7-dimethoxyquinazolin-4-amine | 864289-85-0 | 100.0% | 467.65 g/mol | C27H41N5O2 | 100 MG
C-021 is a small-molecule CCR4 antagonist developed for research applications in immunology and receptor pharmacology. It is provided as a solid powder with high purity and is used in biochemical assays and functional chemotaxis studies.
- Potent CCR4 antagonist with nanomolar activity.
- High purity suitable for biochemical and cellular assays.
- Supplied as a solid powder for flexible formulation.
- Stable when stored under recommended conditions.
- Appropriate for in vitro and in vivo pharmacology studies.
eMolecules 4-Aminoazobenzene hydrochloride | 287481-35-0 | MFCD00012994 | 1g
Combi-Blocks | 4-Aminoazobenzene hydrochloride | 1g | 439372908 | QC-5473 | 95.000 | 287481-35-0 | MFCD00012994 | 233.700 | C12H12ClN3
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC Chromeceptin 5mg | 331859-86-0 | 359.35 g·mol⁻1 | C19H16F3N3O | 5 MG
Chromeceptin is a small-molecule research inhibitor of the IGF signaling pathway that suppresses IGF2 expression and reduces phosphorylation of AKT and mTOR in hepatocyte and hepatocellular carcinoma cells. Supplied for preclinical laboratory use.
- IGF signaling pathway inhibitor.
- Suppresses IGF2 expression at mRNA and protein levels.
- Reduces phosphorylation of AKT and mTOR.
- High chemical purity suitable for preclinical research.
- Available in milligram pack sizes and DMSO solution formats for convenient dosing.
Chemscene ChemScene | 2-Amino-3-hydroxynitrobenzene | 500G | CS-W008642 | 0.98 | 603-85-0| MFCD00010875 | 154.13
ChemScene | 2-Amino-3-hydroxynitrobenzene | 500G | CS-W008642 | 0.98 | 603-85-0| MFCD00010875 | 154.13
![eMolecules Ambeed / Methyl 4H-thieno[32-b]pyrrole-5-carboxylate / 100mg / 490503631 / A128471 / / 82782-85-2 / MFCD06797484 / 181.210 / C8H7NO2S](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502431686.PNG-250.jpg)
eMolecules Ambeed / Methyl 4H-thieno[32-b]pyrrole-5-carboxylate / 100mg / 490503631 / A128471 / / 82782-85-2 / MFCD06797484 / 181.210 / C8H7NO2S
Ambeed / Methyl 4H-thieno[32-b]pyrrole-5-carboxylate / 100mg / 490503631 / A128471 / / 82782-85-2 / MFCD06797484 / 181.210 / C8H7NO2S
Medchemexpress LLC DB04760 (compound 4) | 544678-85-5 | MFCD09878513 | 99.2% | 410.42 g/mol | C22H20F2N4O2 | 10MG
DB04760 is a small-molecule MMP-13 inhibitor (compound 4) reported as a potent, highly selective, non-zinc-chelating inhibitor with an IC50 of 8 nM. It has been used in studies showing reduction of paclitaxel-induced neurotoxicity and anticancer activity, and is supplied for research use with defined purity and solubility characteristics.
- Potent MMP-13 inhibitor with IC50 = 8 nM.
- Highly selective non-zinc-chelating mechanism.
- Molecular formula C22H20F2N4O2, molecular weight 410.42 g/mol.
- CAS number 544678-85-5.
- Purity 99.2%.
- Soluble in DMSO at ≥100 mg/mL; in vivo formulation: 10% DMSO then 90% corn oil.
- Reported to reduce paclitaxel neurotoxicity and exhibit anticancer activity.
- Available in multiple small-scale pack sizes for research use.